Hereditary breast–ovarian cancer syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Hereditary breast–ovarian cancer syndrome
File:PedigreechartC.png
Synonyms	HBOC syndrome
Pronounce	N/A
Specialty	N/A
Symptoms	Increased risk of breast cancer, ovarian cancer, prostate cancer, pancreatic cancer
Complications	Cancer
Onset	Varies, often adulthood
Duration	Lifelong
Types	N/A
Causes	Genetic mutations in BRCA1 and BRCA2 genes
Risks	Family history of breast or ovarian cancer
Diagnosis	Genetic testing, family history
Differential diagnosis	Lynch syndrome, Li-Fraumeni syndrome
Prevention	Prophylactic surgery, surveillance, chemoprevention
Treatment	Surgery, chemotherapy, radiation therapy
Medication	N/A
Prognosis	Varies depending on cancer stage and treatment
Frequency	1 in 400 to 1 in 800 in the general population
Deaths	N/A

Hereditary Breast–Ovarian Cancer Syndrome (HBOC) is a genetic disorder that increases the risk of developing breast cancer and ovarian cancer, among other types of cancer. This syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to increase a person's chance of developing certain cancer types.

Causes

HBOC is caused by mutations in the BRCA1 or BRCA2 genes. These genes produce proteins that help repair damaged DNA, which plays a critical role in ensuring the stability of the cell's genetic information. When either of these genes is mutated, or altered, the protein it produces may not function properly. As a result, cells are more likely to develop additional genetic alterations that can lead to cancer.

Symptoms

People with HBOC have an increased risk of developing breast cancer and ovarian cancer at a young age. Women with this syndrome may also have an increased risk of developing fallopian tube cancer and primary peritoneal cancer. Men with HBOC have a higher risk of breast cancer and may have an increased risk of prostate cancer.

Diagnosis

HBOC is diagnosed through genetic testing for mutations in the BRCA1 and BRCA2 genes. This testing is usually done on a blood sample and can identify the majority of mutations in these genes.

Treatment

Treatment for HBOC involves regular cancer screening to detect cancer as early as possible. This may include mammography, MRI, ultrasound, and CA-125 blood tests. In some cases, preventive (prophylactic) surgery to remove the breasts and/or ovaries may be considered.

See Also

• Breast Cancer
• Ovarian Cancer
• BRCA1
• BRCA2
• Genetic Testing
• Cancer Screening